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adjusting for type of operation, body mass index, chronic
renal dysfunction and presence of chronic lung disease.
Conclusions: In contrast to other surgical sites, local
vancomycin administration did not improve the rate of
short term inguinal wound complications following vascu-
lar procedures. A prospective study is needed to further
delineate the role of local vancomycin adjunct treatment on
inguinal wound outcomes.
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Anesthesia Type and Outcomes following Lower Ex-
tremity Amputations
Michael R. Buckley1, Thomas D. Conlee1, Jeanette An-
drews3, Christopher J. Godshall1, Justin B. Hurie1, Ran-
dolph L. Geary1, Kimberley J. Hansen1, Noel Harrington2,
Matthew S. Edwards1. 1Wake Forest Medical Center De-
partment of Vascular and Endovascular Surgery, Winston-
Salem, NC; 2Wake Forest Medical Center Department of
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Objectives: The purpose of this study is to compare
types of anesthesia in major lower extremity amputations
(LEA) in order to determine whether one type is superior
to another in terms of morbidity and mortality.
Methods: Major LEAs performed between 2005 and
2008 were identified from the American College of Sur-
geons National Surgical Quality Improvement Program
database (ACS-NSQIP) using CPT codes. Anesthesia was
defined as general or regional (epidural, spinal or other
regional). Patient-level co-morbidities and characteristics,
as well as intraoperative and postoperative details were
examined. Complications were analyzed individually, and
in aggregate categories. Procedure-specific variables,
length of stay (LOS), and 30-day mortality were examined.
Characteristics and outcomes were described usingmean
SD or count (%) and associations with anesthesia type were
evaluated for statistical significance. Associations between
morbidity andmortality and anesthesia type were examined
using uni- and multivariable logistic and linear regression
techniques.
Results: 1,592 LEAs were identified for analysis. Of
these, general anesthesia was employed in 1294 (81%) of
these cases. Mean patient age was 68 14 years, 61% were
men, and 66% were white. Overall, the 30-day mortality
was 6.5% (104), any type morbidity occurred in 24.1%
(383), while the mean LOS was 5 (3, 7) days. There was no
statistical difference in the type of surgeon performing the
amputations (85% vascular surgeons overall) between the
types of anesthesia. No univariate differences were observed
by anesthesia type in terms of procedural specifics, LOS or
the occurrence of morbidity (individual or aggregate) or
mortality. Multivariate analyses also demonstrated no rela-
tionship between anesthesia type and the occurrence of
overall morbidity or mortality.
Conclusions: In contemporary surgical practice, based
on outcomes of morbidity and mortality, there appears to
be no difference in anesthesia type when major LEAs are
performed.
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versity Medical Center Utrecht, Utrecht, Netherlands; 2St.
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Objectives: Femorofemoral crossover bypasses
(FFCB) are used in both patients with unilateral iliac artery
occlusive disease (IAOD) and in patients with aortoilliac
aneurysms (AIA) treated with an aorto-uni-iliac stentgraft.
The purpose of this study is to evaluate the durability and
effectiveness of a femorofemoral crossover bypass for pa-
tients with aneurysmal and stenotic arterial disease.
Methods: All patients treated with FFCB for aneurys-
mal or stenotic arterial disease from 2001 to 2011 in 2
Dutch tertiary vascular referral hospitals were included.
Data were retrospectively reviewed.
Results: Ninety-five patients were included. The AIA
group consisted of 48 patients (median age 78 years, IQR
72-84; 36 men) and the IAOD group consisted of 47
patients (median age 71, IQR 63-77; 35 men). Twenty-six
of 48 patients in the AIA group (54%) were treated for
ruptured aneurysms. In the IAOD group Fontaine classifi-
cation was as follows: II 60%, III 21% and IV 19%. Tradi-
tional cardiovascular risk factors were comparable between
both groups.Median follow-upwas 19months (IQR 1-41)
in the AIA group and 28months (IQR 14-50) in the IAOD
group. Primary patency after 2 years was 90% for the AIA
group and 79% for the IOAD group (P  .3). Secondary
patency rates were respectively 100% and 95% (P  .4).
Overall one-year mortality was in the AIA group 10% for
non-ruptured aneurysms and 54% for ruptured aneurysms
and was in the IAOD group 13%. In 6 AIA patients (13%)
bypass related complications were reported (5 stenoses/
occlusions requiring percutaneous transluminal angioplasty
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(PTA) or thromboendarterectomy (TEA) and 1 bypass
infection) versus 15 patients (32%) with bypass related
complications in the IAOD group (4 bypass infections, 2
wound infections, 8 stenoses or occlusions requiring PTA/
TEA (n7) or removal (n1) and 1 ischemic leg) (P 
.05).
Conclusions: Femorofemoral bypasses have compara-
ble patency rates for aneurysmal and occlusive disease.
However, bypass related complications are more often seen
in IAOD patients.
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For Stenting
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Objectives:The retrogeniculate popliteal artery (RGP)
is conventionally regarded as unsuitable for stenting due to
a perceived risk of accelerated restenosis and fracture. This
study sought to evaluate the efficacy of angioplasty (PTA)
alone compared to PTA and stenting in management of
atherosclerotic disease of the RGP.
Methods: Patients who underwent RGP angioplasty
with or without stenting were drawn from a prospectively-
maintained database of patients undergoing lower extrem-
ity intervention. Disease characteristics were obtained from
angiogram and chart review. Primary and secondary paten-
cies as well as limb salvage were calculated using Kaplan-
Meier analysis.
Results: From 2004-2011, 74 isolated RGP lesions
were identified that were primarily treated with PTA. Mean
follow-up was 15.815 months. TASC B, C, and D clas-
sification was 51, 33, and 16% respectively. Procedural
success (30% residual stenosis) was 57% with angioplasty
alone. Overall, 47 lesions were treated with PTA alone and
27 required adjunctive stenting. No significant differences
were found between PTA and PTAS at any time point for
primary, primary assisted, or secondary patencies or for
rates of limb salvage.
Conclusions: The retrogeniculate popliteal artery has
historically been considered a poor location for stent place-
ment in the treatment of atherosclerotic occlusive disease
because of a perceived high risk of complication and accel-
erated restenosis. We show, however, that stent placement
in this location confers no decrease in patency or limb
salvage compared to angioplasty alone.
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Objectives: To analyze the rate of major limb amputa-
tions in North Carolina in relation to physician density and
comorbidities including diabetes (DM), end stage renal
disease (ESRD), peripheral vascular disease (PVD), and
lower extremity ulcers.
Methods: Using the NC Hospital Inpatient Discharge
Database, the rate of hospital discharges with DM, ESRD,
PVD, lower extremity ulcer, or major amputation from
2006-2009 was calculated. The NC Health Professions
Data System was used to define cardiovascular specialist
(CVS; surgeons, cardiologists, nephrologists, radiologists)
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